|[May 08, 2014]
Research and Markets: Xerosis (Dry Skin) - Pipeline Review, H1 2014: 3 Companies and 6 Drugs Profiled
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/qnqlsk/xerosis_dry)
has announced the addition of the "Xerosis
(Dry Skin) - Pipeline Review, H1 2014" report to their offering.
The report features investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from proprietary databases,
Company/University websites, SEC (News - Alert) filings, investor presentations and
featured press releases from company/university sites and
industry-specific third party sources.
Drug profilesrecords featured in the report undergoes periodic updation
following a stringent set of processes that ensures that all the
profiles are updated with the latest set of information. Additionally,
processes including live news & deals tracking, browser based alert-box
and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Laboratoires Pierre Fabre SA
(urea + lactic acid)
For more information visit http://www.researchandmarkets.com/research/qnqlsk/xerosis_dry
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To Technology News's Homepage ]